K. Chapman, R. V. van Zyl-Smit, H. Kerstjens, J. Maspero, Motoi Hosoe, A. Tănase, A. Pethe, P. D’Andrea, D. Brittain
{"title":"评估莫米松(MF)、茚他特罗(IND)和甘替溴铵(GLY)对哮喘控制不充分患者急性发作的减少作用:来自铱研究的结果","authors":"K. Chapman, R. V. van Zyl-Smit, H. Kerstjens, J. Maspero, Motoi Hosoe, A. Tănase, A. Pethe, P. D’Andrea, D. Brittain","doi":"10.1183/13993003.congress-2021.oa1489","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7848,"journal":{"name":"Airway Pharmacology and Treatment","volume":"79 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study\",\"authors\":\"K. Chapman, R. V. van Zyl-Smit, H. Kerstjens, J. Maspero, Motoi Hosoe, A. Tănase, A. Pethe, P. D’Andrea, D. Brittain\",\"doi\":\"10.1183/13993003.congress-2021.oa1489\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7848,\"journal\":{\"name\":\"Airway Pharmacology and Treatment\",\"volume\":\"79 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Airway Pharmacology and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2021.oa1489\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Airway Pharmacology and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2021.oa1489","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study